Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease ; volume:51 ; number:4 ; day:5 ; month:4 ; year:2024 ; pages:385-393 ; date:8.2024
Journal of pharmacokinetics and pharmacodynamics ; 51, Heft 4 (5.4.2024), 385-393, 8.2024
- Creator
-
Nasser, Azmi
Gomeni, Roberto
Ceresoli-Borroni, Gianpiera
Xie, Lanyi
Busse, Gregory D.
Melyan, Zare
Rubin, Jonathan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10928-024-09914-x
- URN
-
urn:nbn:de:101:1-2410080926385.726542272194
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nasser, Azmi
- Gomeni, Roberto
- Ceresoli-Borroni, Gianpiera
- Xie, Lanyi
- Busse, Gregory D.
- Melyan, Zare
- Rubin, Jonathan
- SpringerLink (Online service)
Other Objects (12)
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Deciphering the effects of STN DBS on neuropsychiatric fluctuations in Parkinson’s disease
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson’s disease patient
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Cognitive fluctuations in Parkinson’s disease dementia: blood pressure lability as an underlying mechanism
Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study
Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Deciphering the effects of STN DBS on neuropsychiatric fluctuations in Parkinson’s disease
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson’s disease patient
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Cognitive fluctuations in Parkinson’s disease dementia: blood pressure lability as an underlying mechanism
Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study
Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Deciphering the effects of STN DBS on neuropsychiatric fluctuations in Parkinson’s disease
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson’s disease patient
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Cognitive fluctuations in Parkinson’s disease dementia: blood pressure lability as an underlying mechanism
Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study